ARCHIVES

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

False-Positive Mammograms Can Indicate Higher Cancer Risk

April 27, 2012

Cancer Clinical Trials Approved By NCI Last Month Are Listed

October 25, 2002

Nader Group Backs FDA In controversy Over Drug Testing

February 11, 1977

House Figures for NCI, NIH Will Be Known This Week; Senate Probably Will Wait Until After Recess

July 31, 1987

Some Children With Hodgkin’s Disease Can Reduce Or Skip Radiation, Study Finds

October 29, 2004

FCRF Recompetition Notice Of Intent

September 19, 1980